Kiora Pharmaceuticals, Inc.
KPRX
$2.52
$0.031.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 8.31% | 8.22% | -401.41% | -253.92% | -474.44% |
| Total Depreciation and Amortization | 206.41% | 237.77% | 221.16% | 441.99% | 2,856.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 118.50% | 159.45% | 219.13% | -144.70% | -62.40% |
| Change in Net Operating Assets | -158.52% | -224.07% | -189.21% | -185.04% | 184.88% |
| Cash from Operations | -8.51% | -34.09% | -216.38% | -221.90% | -263.70% |
| Capital Expenditure | -936.72% | -1,738.10% | -1,658.73% | 124.17% | 124.95% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 414.64% | 186.42% | 164.17% | 141.34% | 108.91% |
| Cash from Investing | 405.53% | 185.82% | 163.66% | 141.31% | 108.95% |
| Total Debt Issued | 75.00% | -- | -- | -- | -- |
| Total Debt Repaid | -75.00% | -- | -- | -- | -- |
| Issuance of Common Stock | 1,784.06% | 6.62% | -98.41% | -98.41% | -98.41% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 100.00% | 100.00% |
| Cash from Financing | 1,753.17% | 5.75% | -98.29% | -98.23% | -98.23% |
| Foreign Exchange rate Adjustments | -72.37% | 4,610.26% | 403.67% | -43.49% | 167.71% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 209.04% | 126.12% | 266.71% | -154.07% | -303.05% |